SOURCE: New Wave Holdings, Inc.

New Wave Holdings, Inc.

October 17, 2016 10:15 ET

New Wave's PAO Group, Inc. Focused on Alternative Medicine Clinics - Acupuncture, Chiropractic and Cannabis Hold the Cure for Millions

SANDUSKY, OH--(Marketwired - Oct 17, 2016) -  New Wave Holdings, Inc. (OTC: NWAV) CEO Robert Weber issues a shareholder letter on behalf of PAO Group, Inc., the Company's physicians practice management company actively developing alternative medicine clinics focused on compassionate care for treatment of chronic and terminal patients.

CEO Weber is a seasoned executive and entrepreneur with an extensive background in building businesses to a point of critical mass and exponential growth. Some highlights of his career include building a ground-up enterprise of internet centers in Florida and Ohio. 

In addition to founding PAO Group, Inc., Weber holds ownership in businesses across a diverse base of industry sectors including manufacturing and hospitality. Further, as part of his mission in alternative health and compassionate care, operates a hormone therapy clinic in Southern Florida. He has also served on the Board of Directors for a non-profit organization that championed legislation for small business owners. 

His letter to shareholders is as follows:

Dear Shareholders,

It is a great pleasure to introduce myself and welcome you to a new era for the Company. I am very pleased with the reception we've received to date and thank you for your patience as we embark on the necessary measures to ensure long-term success in line with our core mission: to provide alternative medicine clinics for the care of chronic and terminal conditions.

PAO Group alternative medicine clinics are focused on 'non-traditional' patient care solutions. And yes, cannabis will be included in the realm of treatment solutions as well as other alternative solutions such as acupuncture, chiropractic, biofeedback, and other solutions depending upon patient needs. 

Our nation is suffering an unprecedented opioid epidemic with addictions and overdoses taking the place of cures. The abuse of and addiction to opioids such as heroin, morphine, and prescription pain relievers is a serious problem that affects the health, social, and economic welfare of all societies. PAO Group is well-positioned to fulfill a dire need by providing efficacious solutions to patients as an alternative measure to the pitfalls of opiate-based care.

We'll be issuing a succession of updates reflective of our growth initiatives over the next several weeks, including plans for national expansion, but wanted to take this opportunity to say hello and talk a bit about our next steps.

The Company is currently completing paperwork necessary for name and symbol change, which will be submitted to FINRA for approval so the public company may better reflect PAO Group, Inc. In response to a few inquiries to our Investor Relations department, there will be no reverse split alongside the name/ticker change as we feel there is no need for any type of restructure in the foreseeable future. 

I look forward to updating you with details for the upcoming conference call as well as other news items we'll disperse promptly as they occur. 

Robert Weber

Visit our website at: www.PAO.Group

"Like" and "Share" PAO Group on Facebook /paogroupinc and follow us on Twitter @paogroup

Forward-Looking Statements 
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

Contact Information

  • Contact Investor Relations